From our General Assembly and #AAIC26 to our mid-term review, ISRCTN study registration, Digital Engagement Platform and AD-RIDDLE Academia, it’s been a busy few months! ➡️Discover the latest AD-RIDDLE newsletter: mailchi.mp/8e93b3dc99c3/ad-r… #WorldAlzMonth #WorldAlzheimersMonth

🎓 Today, Sophie van der Landen will defend her PhD thesis. Through her research, she contributed to the IHI projects @AD_RIDDLE and @IHI_PROMINENT. 📖Read our interview with her: ad-riddle.org/from-digital-i… 📍5 November 11:45am CET in Amsterdam: vu.nl/en/events/2026/phd-def…

Last week, we joined 1,400+ delegates at the @AlzheimerEurope Conference #36AEC in Dublin. 🤝3 presentations showcased @AD_RIDDLE's work and we had great exchanges with fellow IMI/IHI projects and opportunities to share AD-RIDDLE flyers! 👉Read more: ad-riddle.org/ad-riddle-at-3…

📢 Lavinia will present “From Prediction to Policy: Health Technology Assessment of Clinical Prediction Models” at #ISPOREurope 2026 in Vienna. 🌐 Learn more: ad-riddle.org/events/

📍 Day 3 at the Alzheimer Europe Conference in Dublin #36AEC Don’t miss today’s @AD_RIDDLE oral presentation: Amran Hawiye will present work conducted at Imperial College London as part of the AD-RIDDLE project and its digital engagement platform.

👉Day 2 at the Alzheimer Europe Conference in Dublin! This morning, Amy Deckert delivered a quick presentation highlighting work related to AD-RIDDLE. Yesterday, Lukas Duffner presented an oral talk, showcasing research conducted as part of our project #36AEC @DavosAlzheimers

📢 The Alzheimer Europe Conference 2026 starts today in Dublin 🇮🇪 We’re excited to be part of this year’s conference #36AEC. If you are attending, don’t miss @LukasDuffner’s oral talk today. 🔎 Find more information about the project: ad-riddle.org/

🧠 How can digital assessments improve dementia diagnosis? Sophie van der Landen explores how digital cognitive and functional assessments can support diagnosis and clinical care. 🎓 Sophie defends her PhD on 5 November. @IHI_PROMINENT @amsterdamumc ➡️ad-riddle.org/from-digital-i…

Today at #IHIForum2026, @imi_epnd announced the launch of EPND+, an independent non-profit organisation that will sustain and develop the EPND Hub. @AD_RIDDLE is already building on this foundation to advance Alzheimer’s research

📢 One week to go until the @AlzheimerEurope Conference #36AEC We’re delighted to see @AD_RIDDLE represented through several presentations showcasing work on Alzheimer’s prevention, detection, biomarkers, policy, practice and Public Involvement. ➡️ ad-riddle.org/events/

📣We’re pleased to share that our multi-site observational study has now been registered with @ISRCTN : isrctn.com/ISRCTN10245911 We’re also delighted that a blog post about @AD_RIDDLE has been published in Springer Nature Research Communities👇 communities.springernature.c…

📢New @AD_RIDDLE publication exploring an innovative payment model for health prevention programs. 👏 Congratulations to all the authors! ➡️ Read the paper here: doi.org/10.1016/j.socscimed.…

#WorldAlzheimersDay featured in Springer Nature Research Communities’ September round-up, highlighting the latest Alzheimer’s research. AD-RIDDLE is featured alongside our new blog post and the registration of our study with the @ISRCTN Registry ➡️communities.springernature.c…

What does it mean to identify Alzheimer's before clinical onset? The September WDC update in @alzdemjournals sets out the questions the Council will put to leaders from government, research, health systems and industry in October: bit.ly/46JTlBZ

🧠 Today, on #WorldAlzheimersDay, we join the global community in raising awareness about #Alzheimer’s disease and #dementia. 👉 Visit our website to learn more about the AD-RIDDLE project: ad-riddle.org #WorldAlzMonth #WorldAlzheimersMonth

The 2026 World Alzheimer Report is now available: A New Era of Dementia Clinical Trials! Dementia clinical trials are bringing new opportunities alongside important questions about how we make research more inclusive, accessible and effective to enable emerging and future innovation for dementia treatments. The 2026 World Alzheimer Report explores key issues including recruitment participation and retention, the importance of global representation, diversification and their impact on inclusive dementia research, and the need to increase awareness and understanding of clinical trials among medical practitioners. The report also explores what clinical trials are and how they work, while sharing personal perspectives and experiences from people involved in clinical research. By bringing together evidence and lived experiences, the report shines a light on recommendations to ensure the next generation of dementia clinical trials are fit to deliver global innovation for future treatments. Download the 2026 World Alzheimer Report today: bit.ly/4iF82gQ #WorldAlzReport #WorldAlzheimerReport #DementiaClinicalTrials #WorldAlzMonth